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Depending on the state or jurisdiction, 
between 8 percent (District of Columbia) 
and 20 percent (West Virginia) of gross state 
product (GSP) is spent on health care.1  From 
1991 to 2004, the average annual percent 
growth in health care expenditures per capita 
in the United States was 5.5 percent with 
higher rates in some states (e.g., 7.8 percent 
in Maine).2  While these spending figures are 
frequently reported, relatively little is known 
about what comprises these expenditures.  
Gaps in that knowledge limit the ability 
to identify opportunities to address rising 
health care costs.  In response to this lack of 
transparency in health care spending, states 
are actively seeking robust information about 
the costs and performance of their state’s 
health care delivery system.  One key source 
of information to support transparency 
and general knowledge of the health care 
marketplace is the development of All-Payer 
Claims Databases (APCDs). 
APCDs are an emerging data source to fill 
critical information gaps as policymakers 
and industry leaders seek solutions for 
transforming health care delivery.  The 
number of states implementing statewide 
APCD initiatives has increased from a 
handful in 2005 to more than a dozen today.  
APCDs can provide information needed to 
develop health care reform efforts that are 
designed to address spiraling health care 
costs, expand access to care, and improve 
public health. To determine new mechanisms 
for the reimbursement of health care, it is 
important to understand the current costs 
associated with various services, providers, 
and facilities; the frequency of having those 
services provided; where care is typically 
delivered (e.g., physician offices, emergency 
rooms); and how care aligns to best practice 
recommendations.   
States have used APCD analyses to answer 
questions in each of these areas. For 
example, states have used APCD data to: 
• Develop a tiered-network insurance 
product for the small group 
marketplace (New Hampshire); 
•  Provide cost information to support 
consumer-driven health care 
choices, providing information 
about the varying cost of procedures 
in different medical facilities 
(Massachusetts, New Hampshire, 
Maine);     
•  Help employers understand 
variations in the cost and utilization 
of services by geographic area and in 
different provider settings (Maine, 
New Hampshire);
•  Explore the value equation (cost and 
quality) for services provided (New 
Hampshire); 
•  Inform the design and evaluation 
plan of payment reform models 
including the medical home model 
and accountable care organizations 
(Vermont, New Hampshire);
•  Evaluate the effect of health reforms on 
the cost, quality, and access to care in a 
state (Vermont, Maryland);
•  Compare the prevalence of disease 
across a population (New Hampshire, 
Utah);
•  Compare utilization patterns across 
payers to inform state purchasing 
decisions for programs such as 
Medicaid (New Hampshire) and to 
identify successful cost containment 
strategies (Vermont, New Hampshire);
•  Determine payer competitiveness 
within the commercial insurance 
market (New Hampshire); and
•  Estimate the cost of potential legislative 
changes affecting health insurance 
and later calculate the actual cost and 
impact of the legislation.
States with APCDs are providing a 
roadmap for implementation that other 
states can apply, making it feasible for 
almost every state to establish an APCD 
reporting program in the future.  
 
 
This brief provides an overview of statewide 
APCDs and covers the following topics: 
•  What are APCDs?
•  In what states do APCDs currently exist 
and what states are exploring APCDs?
•  Why develop APCDs?
•  Who are the stakeholders of APCD 
systems?
•  What are the major concerns or 
challenges related to APCDs and how 
they have been addressed?
•  How are states using APCD 
information?
•  How are APCDs governed and funded?
What are APCDs?
APCDs are large-scale databases that 
systematically collect health care claims 
data from a variety of payer sources. 
Statewide APCDs are:
Databases, typically created by a state 
mandate, that generally include data 
derived from medical claims, pharmacy 
claims, eligibility files, provider 
(physician and facility) files, and dental 
claims from private and public payers.  
In states without a legislative mandate, 
there may be voluntary reporting of 
APCD data. 
Making the Political Case
The health care reform debate is happening 
and All-Payer Claims Databases must focus 
on the value of the information for reform.  
Health care markets are regional rather than 
national, so states must lead the way and 
work together to advance all stages of APCD 
development, including: 
• Aggregation across markets and states
• Translation into actionable information
• Applications/use to improve decisions
• Enhancement of APCD through linkage of 
claims with clinical data
Source: Gov. Michael O. Leavitt 
NAHDO/SCI APCD Meeting, October 14, 2009
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APCD systems have generally been 
developed in one of two ways:  legislatively 
mandated data collection systems; or 
private and voluntary data collection.  
Although there are exceptions, most 
state-mandated programs require data 
submission from all payers with penalties 
for non-compliance.  In state-based 
systems, information is typically made 
available to the general public at no or 
low cost with appropriate restrictions on 
data release.  Private APCD initiatives 
typically rely on voluntary participation 
and are more likely to limit data release 
to subscribers and members.  Thus, the 
greatest differences between a public and 
a private APCD are around mandatory 
data submission and public access and 
data reporting.  Voluntary initiatives may 
be more flexible in their operations and 
provide important information to their 
participants, but may not meet the needs 
of states seeking information to support 
public reporting and policy purposes on a 
statewide basis.   For example, a voluntary 
initiative may not be as comprehensive 
as a mandated reporting effort as some 
carriers may choose not to submit data or 
may submit incomplete data, and there 
are no legal penalties for non-compliance.   
It is important to note that these private 
initiatives may serve as a pilot for eventual 
statewide APCD systems.  The consensus-
building process and stakeholder buy-in 
required for voluntary programs may 
prove beneficial as the APCD matures.  
Since the majority of state APCDs are 
publicly funded, this brief primarily 
focuses on publicly funded state initiatives. 
Payers include insurance carriers, third 
party administrators (TPAs), pharmacy 
benefit managers (PBMs), dental benefit 
administrators, Medicaid, Children’s Health 
Insurance Program (CHIP), Medicare, 
Medicare Part D, Federal Employees Health 
Benefits (FEHB), and TRICARE. 
APCD systems collect data from the 
existing transaction systems in place to 
pay health care claims, thus leveraging 
data from within the insurance claims and 
reimbursement system.  The information 
typically collected in an APCD includes 
patient demographics, provider 
demographics, clinical, financial, and 
utilization data.  Because of the difficulties 
associated with the collection of certain 
information, most states implementing 
APCD systems have typically excluded a 
number of data elements, such as denied 
claims, workers’ compensation claims, and 
services provided to the uninsured.
Status of State-based 
APCD Development 
Figure 1 contains a map of the states that 
have an existing APCD, have one under 
development, or have strong interest in 
creating one. Strong interest could range 
from exploration of funding models or 
development of legislation. Oregon and 
Tennessee will have live systems in 2010.  
In the current economic climate, states 
wishing to develop APCDs are finding 
budget challenges as it relates to initial and 
sustaining funding for their future APCD. 
(See section below on funding APCDs) 
Figure 2 details the year that each state’s 
system went live (when they began 
collecting data for their APCD)  



















































*Not a state administered system 
Being Implemented
Strong Interest 
Legislation enacted without funding 
Figure 1: Status of All-Payer Claims Databases as of May 2010
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Adoption Model for 
Populating an APCD
Prior to creating an APCD, states should 
develop a model for populating their 
APCD.  This model will assist the state 
by laying out the framework and the 
order by which data will be brought into 
the APCD.  It should be acknowledged 
that there is no one model for states to 
adopt.  To date, states have successfully 
integrated claims from commercial 
payers, third-party administrators (TPAs), 
pharmacy benefit managers (PBMs), 
dental benefit administrators, Medicare 
Parts A-D, Medicaid, and CHIP.  Figure 
3  demonstrates the full range of sources 
of claims data that, ideally, would be in a 
state’s APCD as the APCD evolved.  This 
model would provide the most accurate 
picture of all health care services being 
provided to a state’s residents.  
The items shown in the inner-most 
ring of Figure 3 are data sources that, in 
addition to uninsured data, states desire to 
complete their APCDs. To date, states have 
not been able to implement collection of 
these sources due to lack of access to the  
 
data sets.  For example, a state such as 
Hawaii, with a large military population, 
has more than 100,000 individuals 
covered by TRICARE (representing a 
little less than 10 percent of the overall 
population).  This is a significant 
population not currently captured.
By developing an adoption model, states 
can prioritize the sequence in which data 
sets will be added to develop the APCD.  
This is important as it will assist them in 
developing cost estimates for the APCD, as 
well as help determine which constituents 
will benefit from the APCD initially and 
over time.  If, for instance, Medicaid fee-
for-service was not included initially, 
public program officials would be unable 
to use claims data to make programmatic 
improvements to Medicaid.  Each state 
APCD that has been developed to date 
has had differences in its adoption model.  
Typically, commercial claims, pharmacy 
claims, and Medicaid claims are the first 
data for adoption.  A well thought-out 
adoption model is important for short- 
and long-term planning efforts in the 
development and maintenance of a  
state’s APCD.
Figure 2: Timeline for State APCDs
Year in Which State’s System Went Live and Furthest Year of Historical Data
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* Shaded rows indicate non-state administered systems
Information typically collected  
in an APCD
• Encrypted SSN or member identification 
number
•  Type of product (HMO, POS, Indemnity, etc.)
•  Type of contract (single person, family, etc.)
•  Patient demographics (DOB, gender, zip)
•  Diagnosis, procedure, and NDC codes
•  Information on service provider
•  Prescribing physician
•  Plan payments
•  Member payment responsibility 
•  Type and date of bill paid
•  Facility type
•  Revenue codes
•  Service dates
Data elements typically excluded  
in an APCD
• Services provided to uninsured  
(few exceptions)
•  Denied claims




• Back end settlement amounts
• Referrals
• Test results from lab work,  
imaging, etc.





A major advantage to having an APCD 
is the ability to understand—in ways 
not otherwise possible—how and where 
health care dollars are being spent.  This 
understanding of health care expenditure 
patterns and the performance of the 
health care system, via quality and access 
metrics, is vital to develop data-driven 
health reform efforts resulting in impacts 
(including improved access to care, 
reduced costs, and improved quality) that 
can be effectively measured. 
Limitations of Current Data Sources
Current data sources are insufficient to 
inform and affect change in our health 
care delivery system.   
Data Sources with Limited Service 
Sites: Examples of commonly used data 
for understanding health and health 
care include claims and other data from 
certain sub-populations (e.g., hospital 
discharge data and Medicare claims data) 
and sample-based data (e.g., the Medical 
Expenditure Panel Survey [MEPS] and 
the National Ambulatory Care Survey). 
Though the majority of health care 
in the United States is received in the 
outpatient setting, data and analysis for 
office-based care or pharmacy information 
at the population level are not publicly 
available.  According to the 2005 MEPS, 
71.3 percent of the U.S. population had 
a health care expense related to an office 
visit. In comparison, the percent with 
inpatient hospital, outpatient hospital, or 
emergency room expense was much lower: 
7.5 percent, 15.8 percent, and 12.9 percent, 
respectively.3  
Data Sources with Limited Populations: The 
Centers for Medicare & Medicaid Services 
(CMS) collects and makes data available 
based on claims paid by Medicare, including 
ambulatory care. This is another rich set of 
data, but limited. Much of the health care 
reform debate and policy decisions have been 
made based on these data,4 despite the reality 
that the data are limited to people covered 
by Medicare (those 65 and older or with 
certain medical conditions).  In addition, 
there can be a lengthy time delay before states 
and others can get access to Medicare data, 
making it less useful for the evaluation of 
ongoing reforms.
State-based Medicaid program data also 
provide a wealth of information about 
the type, quality, and cost of care for the 
Medicaid population.  However, like 
Medicare data, Medicaid reflects only a 
small, albeit very important, portion of the 
population for most states.  MEPS reported 
that, in 2007, public insurance covered only 
about 20 percent of the population; private 
insurance was the most common type of 
health insurance among the civilian non-
institutionalized population, with more than 
60 percent of that population having private 
health insurance coverage.5  Further, 41.6 
percent of medical expenses were paid by 
private insurance.6  It is within the private 
coverage system that payment rates vary most 
significantly. The impact of public program 
policies is often felt in the private sector and, 
with an APCD, it is possible to measure the 
impacts on the system as a whole. 
How Can APCDs 
Overcome These 
Limitations 
As noted, although policymakers have 
good options for data in the Medicare 
and Medicaid populations, and for many 
hospital-based services, data about the 
experience in ambulatory care for the 
majority of the U.S. population who are 
commercially insured are not available for 
most states.  APCDs capture data from 
office-based care, filling an important 
information gap. 
Recognizing the need for more robust 
health care delivery data, a growing 
number of states are establishing, or are in 
the process of establishing, APCDs, which 
hold the potential for a much deeper 
understanding of patterns, quality, and 
cost of care across the entire population.  
Policy and research questions that can be 
answered using APCDs include:
•  Which hospitals have the highest 
prices?
•  Which health plan has the best 
discounts?
Commercial & 
TPAs  & PBM 
& Dental & 
Medicare 
Parts C & D 
Medicaid FFS 
& Managed 
Care & SCHIP 
Medicare 




Figure 3: Sources of APCD Data
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•  What percentage of the population has 
had a mammogram?
•  If emergency room usage by Medicaid 
members is higher than by the commercial 
population, what are the causes? 
•  What is the average length of time 
people are using antidepressant 
medications and what are the patient 
demographics?
•  How far do people travel for services?  
And for which services?
•  What are the utilization patterns 
and rates for Medicaid compared to 
commercial policyholders?
•  What are the gaps in needed disease 
prevention and health promotion services?
•  Which parts of a state have better access 
to specialists?
•  Are established clinical guideline 
measurements related to quality, safety, 
and continuity of care being met?   
What are the Benefits 
to Stakeholders?
The crux of these databases is having true 
transparency across the entire spectrum of 
health care payers.  With such transparency 
comes access, for a wide variety of 
stakeholders, to information that has never 
before been available, thus creating the ability 
for actionable and accountable measures. 
For providers, APCDs have the potential to 
promote quality improvement.  Payers have 
information to reward the delivery of high 
value and efficient care.  And, consumers have 
information to make rational choices based 
on cost and quality information.  States that 
have successfully created APCDs have fully 
engaged all stakeholders in the planning and 
implementation process.  The stakeholders 
and the benefits for each group include the 
following:
Benefits for Policymakers
States are experiencing unprecedented 
fiscal crises, with most states estimating 
shortfalls in their 2010 budgets.  Medicaid 
expenditures are a major cause of these 
shortfalls, especially as enrollment increases 
as a result of growing unemployment rates.  
Serious decisions are being made by states 
including options for payment reform, 
provider systems accountability, and health 
insurance reform.  APCDs can guide health 
care reform policies and are a relatively 
small investment in terms of health care 
expenditure.  
Oregon is seeking options for payment 
reform, but before implementing policies, 
lawmakers recognized a basic need for 
additional information on how spending 
is distributed through the system. That 
required data that the state does not 
currently have.  To fill this information 
gap, legislation to establish an APCD 
reporting system was passed in Oregon in 
2009.  Maryland’s payer reporting system 
was linked to broader health care reform 
initiatives in 1993, as was Maine’s in 2003.  
As hospital reporting systems have 
demonstrated, outcomes and savings 
that can be measured will propel reform 
efforts.  A recent study in the American 
Journal of Medical Quality (AJMQ) 
estimated that Pennsylvania’s Health 
Care Cost Containment Council (PHC4) 
public reporting process prevented 1,500 
deaths in one year in just six disease and 
treatment categories.   This AJMQ study 
validates PHC4’s own internal findings that 
improvements in hospital care during the 
last 12 years of public reporting have saved 
an estimated 49,000 lives. 7,8 
APCDs are a new data system, with less 
history than hospitalization data, but have 
similar potential for improving health care 
delivery.  As more states aggregate and 
use all-payer databases, the knowledge 
base will increase along with comparative 
statistics to reveal variation and identify 
best practices in transparency, payment 
reform, and industry accountability at the 
same time as informing state and local 
health care policy.
Benefits for Consumers
Consumers have much to gain from 
APCDs.  Several states have developed 
websites providing cost information 
to consumers on specific procedures 
for specific providers and carriers.  For 
example, Massachusetts, Maine, and 
New Hampshire have produced health 
cost websites that allow consumers to 
compare pricing of medical procedures 
by health care provider.  The majority 
of states plan to add quality measures 
to their consumer-oriented reports and 
state-sponsored websites as these measures 
are developed.  These data can be used to 
help patients select high-quality, low-cost 
providers.  Benefit design changes can be 
made to plans to promote more rational 
decisions and enable consumers to become 
part of the cost solution.  For those who 
are uninsured or have high-deductible 
plans, having access to accurate, reliable 
pricing information is critical.  These 
sites provide both charge and negotiated 
discount information for consumers so 
that, depending on their benefit plan type, 
the information they need is available. For 
example, New Hampshire has developed 
a consumer-focused website that allows 
individuals to input information about 
the design of their health plan and be 
APCD Value Proposition
Facilitating research to support state goals 
• Comparative effectiveness, patient-centered 
medical home, payment reform.
Informing and monitoring reform 
• Costs, access, quality – transparency. 
Democratizing information 
• Equal access to information for innovation and 
competition.
Reinforcing communities of interest 
• Network map of shared patients for care 
coordination.
Population health management 
• Public and private, more complete 
representation of population.
Better precision for pay-for-performance 
• Aggregation across multiple payers for each 
clinician helps ensure sufficient sample size.
Supporting delivery system transformation 
• Episodes, global payments, system level 
measures.
Producing quality indicators 
• Development of algorithms for measuring 
clinical pathways.
Based on presentation by Dwight McNeill, NAHDO/SCI
APCD Conference, October 2009 
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provided with the cost of a procedure for 
different hospitals. This allows consumers 
to understand where they might seek the 
most affordable care.
Even if consumers do not directly use public 
cost and quality information, research has 
shown that consumers benefit indirectly as 
the providers improve quality in areas with 
public quality reports.9  Work still remains 
to be done to bring additional quality 
and preventive services information to 
consumers.  Some employers have access to 
this information, but have not yet actively 
made it available to their employees.  
Benefits for Researchers 
As previously described, the majority of 
health care services are delivered in the 
primary care and outpatient settings. Data 
that describe this level of service delivery 
is lacking. Public insurance data (e.g., 
Medicare and Medicaid) are available for 
the population with this type of coverage, 
but these fail to capture the majority of 
the population. Thus, health services 
researchers have few options for data that 
support research about health care delivery 
in the most common setting (primary care) 
and for the majority of the population 
(those covered by commercial insurance).  
APCD data help to fill that void.
Examples of research uses for APCDs 
include a study that used methodology 
developed by the Agency for Healthcare 
Research and Quality (AHRQ) to analyze 
APCD data to determine the scope and 
costs associated with adverse drug events 
(ADE). The report, which focused on 
Maine and New Hampshire, found that 
more than $30 million was spent on ADE 
discharges across the two states during the 
two-year analysis period.10    
An additional study focused on the level 
of patient migration in New Hampshire. 
The study used the APCD to determine 
the amount of care that was delivered to a 
population outside of their local “capital 
health analysis areas” (defined as a region 
served by one or more hospitals). The study 
found that some residents were receiving care 
outside of their local area for up to 60-70 
percent of their medical services.11   This is 
important for planners of health information 
exchange (HIE) so that they can understand 
the flow of patients and prioritize making 
electronic connections between providers in 
different communities. 
Benefits for Providers
Though hospital quality reports are 
increasingly available, very little is 
known about physician performance 
and variation.  APCDs are expected to 
help disrupt the industry’s tolerance of 
performance blindness.  Currently, some 
payers mine their own claims data systems 
for quality and utilization reports and 
share this information with physicians 
and enrolled subscribers.  Because the 
information is limited to the insurer’s 
network, it may not be statistically 
significant at the individual physician 
level, due to small numbers of events.  
CMS recognizes the need to move beyond 
the analysis of physician performance 
using Medicare data alone and is seeking 
options for APCDs to add power to their 
performance evaluations.  Once physician 
attribution issues are resolved (i.e., how 
to assign patients to physicians especially 
in a complex treatment case with multiple 
providers), states with APCDs will be in a 
good position to look across payer systems 
and determine how markets and regions 
compare in value and efficiency.
Providers will benefit from data aggregated 
across the whole system to reveal a robust 
snapshot of care in all settings and from 
all types of payers.  Most states plan to 
develop episodes of care data to assess 
efficiency in both inpatient and outpatient 
services.  Vermont and New Hampshire 
will use their statewide APCDs to evaluate 
the effectiveness of their medical home 
models for delivering care.  
Benefits for Employers
Many of the transparency benefits for 
consumers also apply to employers.  For 
those employers offering high-deductible 
plans or tiered networks, APCD data can 
assist the employees in their decision-
making process.  In addition, employer 
coalitions have used APCD data to 
benchmark cost, quality, preventive service 
measures, and high-cost cases across their 
populations.  This information is used to 
improve health and wellness programs 
and to more deeply engage the employers’ 
carriers in joint program development.   
Finally, to educate their employees and 
to engage the hospital community, two 
states (Maine and New Hampshire) 
have released hospital scorecards with 
cost and quality data.  The cost data 
is derived from the APCDs.  The New 
Hampshire Purchasers Group on Health 
releases this information quarterly to its 
employees as part of  its core education 
programs.  Moving forward, employers 
will do additional benchmarking against 
statewide metrics and continue to focus on 
cost reduction, quality improvement, and 
employee engagement.
APCDs and Quality of Care Delivery
Claims data are an excellent source of information about health care cost and utilization. 
They can also be used to measure the quality of care, though they have both strengths and 
weaknesses for use in this area. The advantage they have over clinical data is that they are 
available electronically and do not require time-consuming chart reviews or the requirement 
that providers enter clinical data into a registry. More sophisticated methodologies and 
algorithms are being developed that allow claims data to be aggregated into episodes of 
care and other bundles that gives more robust quality information. Claims data could be 
further enhanced if basic lab values were included in claims. It could also be blended with 
information in electronic medical records (EMR), although the United States’ system is a 
long way from widespread EMR adoption. Even when EMRs are fully implemented across 
the health care system, the technology will need to be developed and improved to enable 
the data from EMRs to be integrated with claims data to allow ideal analysis of the value of 
care (an indicator that incorporates both the cost and quality of care).
Source:  “Adding Clinical Data Elements to Administrative Data for Hospital-Level Reporting.”  Final Report AHRQ 
Contract #233-02-0088, Task Order 13, Vol. 1, July 3, 2006.  
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Benefits for Public Health
All-payer claims data are an important 
source of information for public health 
and community health needs assessments.  
APCDs provide population-based 
health care data for program policy 
and evaluation in a growing number 
of states.  States with APCDs can now 
measure the rates of disease prevalence 
of chronic conditions and access to 
health care services, and make geographic 
comparisons to study variation in these 
measures. Episodes of care analyses for 
chronic illnesses and cancer will promote 
opportunities for targeted interventions 
and improvement.   In 2007, with 
funding from the Centers for Disease 
Control and Prevention (CDC), the New 
Hampshire Assessment Initiative began 
development of chronic disease indicators 
based on APCD data. The claims data 
will be part of the state’s Web-based data 
query system, and will supplement the 
information available through other 
administrative data sets (hospitalization, 
mortality, birth, and other data) about 
the disease profile and opportunities for 
public health intervention.  The data 
are currently being used to understand 
Emergency Department (ED) use for 
people with mental illness, which will help 
shape community-based interventions to 
address the root causes of inappropriate 
ED use. These efforts are advancing the 
understanding of the utility of claims data 
to assess the public’s health.
Benefits for Medicaid 
The inclusion of Medicaid data in an 
APCD provides Medicaid programs with 
information that can be used to support 
policy development and inform the design 
of Medicaid programs. APCDs provide 
benchmarking for Medicaid payments 
compared to commercial plans and can 
support payment reform efforts. 
The New Hampshire Medicaid program 
has used APCD data to support several 
policy efforts.  APCD data were used to 
compare rates of ED visits for the Medicaid 
population compared to people covered by 
commercial insurance. The analysis showed 
higher ED utilization among Medicaid 
recipients and those findings have driven 
efforts to reduce ED use. Another example 
is a report published by the New Hampshire 
Office of Medicaid Business and Policy 
that compares the use of preventive health 
services for the population with Medicaid 
coverage, compared to the commercially 
insured population. The findings of the study 
highlight opportunities for improvement in 
the use of preventive services (e.g., cancer 
screening, asthma medication) in the 
Medicaid population.12  This information 
has been used by the state to shape care 
coordination efforts.
Benefits for Commercial Payers
There are many opportunities for 
commercial payers as well. The benefits for 
commercial payers will vary depending on 
a state’s data release rules, which will dictate 
how much information the payers will have 
access to.  If, for example, payers can access 
provider identification number as well as 
competing payer identification numbers, 
then they can use this information in their 
provider contracting negotiations.  In New 
Hampshire, payers (and providers) are using 
analyses of APCD data to assist in their 
negotiations.  Again, depending upon release 
rules, carriers can evaluate cost, quality, and 
utilization rates across the entire population 
of a state as a way of benchmarking their 
performance.  They can also benchmark 
themselves against their competitors and 
public programs, such as Medicaid.   While 
there is no evidence of it yet, these databases 
could assist commercial payers in developing 
new insurance products based upon 
additional information gleaned from the 
database.
How Some Common 
Data Challenges Can 
be Addressed
States implementing APCD reporting 
systems will need to address important 
concerns, including patient privacy, 
payer reporting burden, data access, and 
identification of data users.  States with 
APCD reporting systems have developed 
solutions to address those concerns, which 
can serve as lessons for other states. 
Patient Privacy
State health data agencies and public 
health authorities have managed sensitive 
health care data and have protected 
the privacy and confidentiality of their 
data for many years.  With legislative 
protections controlling data access and 
release provisions, combined with strong 
management controls, agencies have 
proven that they can balance privacy 
concerns with the public good that health 
care data provide.  These agencies also 
recognize the importance of protecting 
individual privacy and respecting 
individual dignity to maintain the quality 
and integrity of health data.13  The CDC 
and others have worked consistently to 
strengthen federal and state public health 
information privacy practices and legal 
protections.14
Various approaches states are taking in 
response to privacy concerns include: 
not collecting direct identifiers; adopting 
encryption methodologies; and restricting 
the release of information that can 
directly or indirectly identify an individual 
patient.  Some states, like Minnesota, 
will not permit the release of detailed 
data outside of the authorizing agency.  
States can impose penalties for misuse or 
inappropriate disclosures.  Some of these 
restrictions and limitations may not be 
ideal from a data-use perspective, but they 
can be used to further increase the security 
of the data.
Payer Reporting Burden
APCD data collection and reporting is not 
without costs to those who must supply 
the data.  A key advantage of using billing 
data from payers is that, by leveraging 
the claims reimbursement transaction 
system, payer and provider reporting 
burden is reduced.  Because data are 
generated automatically for every medical 
encounter in a standardized format, the 
use of existing data minimizes reporting 
costs.  To the degree that states adopt a 
uniform reporting format, national payers 
will not bear the compounded costs of 
responding to unique state reporting 
requirements. States are working with 
the National Association of Health Data 
9
Organizations (NAHDO), the Regional 
All-Payer Healthcare Information 
Council (RAPHIC), and America’s Health 
Insurance Plans (AHIP) to harmonize their 
collection requirements to align with payer 
capabilities.
Data Use and Access
Most state APCD programs will make 
the information available in various 
formats for external and internal users.  
Though most states have a long history 
of reporting hospitalization data, in some 
states the APCD data set has posed unique 
challenges, largely because it includes 
payment information.  To overcome 
those challenges, states aggregate and 
protect proprietary and other sensitive 
information. Ultimately, the community 
benefits by having access to a common 
source of health care systems data.  States 
that develop a consensus plan on data uses 
that range from public statistics to health 
services and public health research will 
increase stakeholder support and trust.  
By designing data release policies that are 
consistent with these uses and that provide 
equitable access to legitimate users, the 
return on investment of an APCD system 
can be realized while providing assurance 
that the data are secure and privacy is 
maintained.
What are the General 
Ways of Governing 
and Funding an 
APCD?
States have adopted several approaches 
to governance and funding of an APCD 
system.  This variation reflects the political 
environment in each state.  There is no 
one-size-fits-all approach, and each has 
advantages and disadvantages.  Ideally, 
an APCD data steward should be seen 
as a neutral or independent entity that 
is credible and trusted by all of the 
stakeholders.  However, local environments 
vary and factors may preclude achieving 
the “ideal,” so states must choose the 
approach that is most practical. 
Governance 
Generally, authority to establish a state-
based APCD is developed through 
legislation.  This allows a structure of broad 
legislative authority and enables states to 
craft the details about data collection and 
release through the regulatory and rule-
making process.  This permits flexibility 
and specificity in data collection and 
release. In some states, an existing  state 
agency oversees the collection and release 
of APCD data.  The state agency often 
leverages its hospital reporting program 
infrastructure, expanding its authority 
and reporting regulations to encompass 
APCD requirements.  This is the case for 
Massachusetts, where the APCD resides 
with the Division of Health Care Finance 
and Policy within the Office of Health 
and Human Services.  In Tennessee, the 
APCD will reside under the authority of 
the Division of Health Planning in the 
Department of Finance and Administration. 
In both cases, the APCD is grounded in 
agencies tied to state health policy.
In other states, the APCD resides with 
an agency responsible for oversight 
of insurance carriers and/or licensing 
of carriers, as in Vermont, where the 
Department of Banking, Insurance, 
Securities, and Health Care Administration 
manages the APCD.  In New Hampshire, 
it is a shared structure of governance 
between two state agencies.  Through a 
memorandum of understanding, both the 
Department of Health and Human Services 
and the Department of Insurance share 
in the management of data collection and 
release, as well as production of APCD data 
analysis and reports.   
In Maine, the authority was granted 
legislatively to the Maine Health Data 
Organization (MHDO), which is charged 
with the collection and analysis of claims 
data as well as hospital quality data 
for Maine residents.  The MHDO was 
established by the Maine legislature in 
1996 as an independent executive agency 
to collect clinical and financial health care 
information and to exercise responsible 
stewardship in making this information 
accessible to the public. MHDO policy is 
governed by a 21-member policy board 
that represents health care providers, 
payers, and consumers.  
Broad stakeholder input and a fair 
decision-making process is essential to 
building a community data system that 
meets the diverse needs of the users for 
multiple uses.  Some states have established 
statutory commissions or advisory boards 
comprised of all of the major stakeholders.  
For example, Utahs APCD is governed by 
the Health Data Committee, established 
by the Utah Health Data Authority Act 
and representation is mandated for key 
stakeholder groups, including consumers.  
In Tennessee, the legislation required the 
establishment of the Tennessee Health 
Information Committee made up of state 
commissioners and key stakeholders to 
provide guidance to the Commissioner 
of Finance and Administration on 
polices relating to the establishment and 
management of the state APCD.  A private 
initiative may operate under the direction 
of a Board of Directors such as the Puget 
Sound Health Alliance in Washington.  
Despite the structure, a key success factor 
to any APCD initiative will engage all 
of the major stakeholders, including 
consumers, to assure that decisions about 
data collection, use, and access reflect the 
community’s needs and that solutions to 
technical issues are addressed. 
Funding
The key to a stable statewide health data 
program is a stable source of ongoing 
funding.  Like other state data systems, 
the start-up and maintenance costs are 
significant.  Unlike other state data systems, 
such as vital statistics, APCD programs 
receive no direct federal funding, although 
some states have been able to use Medicaid 
federal match funding to partially support 
APCD development.  In states that have 
mandated reporting, funding often comes 
from either general funds or mandatory 
fees from providers or insurers.  Voluntary 
APCD programs are usually funded 
through membership fees and/or grants 
and contracts.  All programs—mandatory 
and voluntary—can expect some degree 
of revenue from data product sales once 
the system is operational.  In all types of 
programs the cost of submitting the claims 
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in the correct format are typically borne 
by whoever collects the data: the payers, 
insurers, or the state.  
The funding for APCDs is somewhat tied 
to the governance structure.  In Maine, 
the MHDO has legislative authority to 
equally assess fees on health care providers 
and payers.  Revenues are derived from 
fees assessed on hospitals (based on net 
patient service revenue), carriers (based on 
premiums written and as reported to the 
Insurance Commissioner), and from TPAs 
(based on claims paid for plan sponsors).  
The fees are assessed based on relative 
market share.  MHDO also receives a small 
amount of revenue (less than 5 percent 
of the annual revenue) from the sale of 
the data.  Fees are placed in a dedicated 
account, not the general fund, and 
unexpended revenues carry over into the 
next fiscal year, with assessments adjusted 
downward accordingly.  
Other states rely on general appropriations 
from the legislature.  In the case of New 
Hampshire, the APCD is funded primarily 
through state budget funds for the 
responsible agency or department.  Fees 
collected from releases of data, and fines 
collected from non-compliant carriers 
(those that have failed to submit data, etc.) 
are insignificant and account for only a 
small portion of funds that can be used to 
sustain the APCD.
Conclusion
Despite pressure to transform health care 
delivery and assess the value of health 
care services, states have realized that the 
information needed to support health care 
reform is not available.  In response, states 
are creating APCDs to drive decisions and 
create transparency.  Statewide APCDs are 
evolving and are increasingly becoming 
an important source of information for 
state policymakers, consumers, purchasers, 
and other stakeholders.  States have 
demonstrated that the collection of APCD 
data is definitely feasible and can be quickly 
implemented.  In the absence of legislative 
authority, some states are relying on 
private, voluntary initiatives to fill critical 
information gaps.  Both state agencies and 
private entities face an array of challenges 
to APCD implementation that range from 
funding to data release practices, with 
variation across states in how they are 
addressing these challenges.  As the number 
of states with APCD programs increase, 
the payer burden to supply the data also 
increases.  States are working to harmonize 
their collection requirements to align with 
payer capabilities.  As the uses of APCD 
data evolve, states will share reporting 
methods and tools to better translate their 
databases into actionable information for 
policy and market purposes.    
A Call to Action
States need access to timely and state-specific 
information for their policymakers and 
consumers to support  evidence-based 
decisions.  APCDs are unique in that they 
provide detailed, systemwide information 
to support payment reform and market and 
policy decisions.  As more states implement 
APCDs, these systems have potential 
to support national reform efforts and 
comparative effectiveness research studies.  
Integration of APCD reporting with state-
level HIEs will leverage emerging information 
technology to generate clinically robust 
population-based data.
The question before states and the 
federal government is how APCDs will 
be authorized, funded, maintained, and 
utilized to support these reform efforts 
most efficiently and effectively.  The states 
and the federal government should work 
together to explore how to leverage APCDs 
by integrating these systems into statewide 
and national information initiatives.
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